Integrated Immune Profiling of Peripheral Blood & Tumor Tissue for Rational Stratification of Patients in Immunotherapy Trials
Time: 2:35 pm
day: Day Three Track B
Details:
- Identification of Immunological Signatures: Overlapping immunological signatures with putative treatment mechanisms of action (MOA) can significantly increase the probability of successful outcomes in immunotherapy trials
- Immune System Profiling: Profiling the immune system can identify a patient’s immune status, which may reveal resistance to various immune-based treatments. This information is crucial for tailoring personalized immunotherapy strategies
- Evaluation of Transcriptional Profiles: Assessing the transcriptional profiles of peripheral immune cells and circulating cell-free RNA can uncover dynamic prognostic biomarkers. These biomarkers are essential for predicting drug response and guiding treatment decisions in real-time
